drugset / Trial / NCT00212680

Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan

NCT00212680

Phase 2 Completed 100 enrolled Ono Pharma USA Inc
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to evaluate the dose-dependent effects of ONO-1101 on efficacy and safety in patients with postoperative supraventricular tachyarrhythmias.

Timeline

Start
1996-12
Primary completion
2006-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Landiolol Small molecule

Indications